Advertisement

PharmacoEconomics & Outcomes News

, Volume 820, Issue 1, pp 38–38 | Cite as

NICE recommends venetoclax plus rituximab for adults with CLL . . .

News item
  • 4 Downloads

References

  1. 1.
    NICE. Thousands of adults with chronic lymphocytic leukaemia to benefit from new treatment option. Internet Document : 18 Jan 2019. Available from: URL: https://www.nice.org.uk/news/article/thousands-of-adults-with-chronic-lymphocytic-leukaemia-to-benefit-from-new-treatment-option
  2. 2.
    NICE. New migraine drug not cost-effective NICE says in draft guidance Internet Document : 10 Jan 2019. Available from: URL: https://www.nice.org.uk/news/article/new-migraine-drug-not-cost-effective-nice-says-in-draft-guidance

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations